This study shows that overweight and obese patients with atrial fibrillation experience improved outcomes when treated with DOACs compared with VKAs. Specifically, DOAC use was associated with lower risks of all‐cause mortality and cardiovascular events.
Danilo Menichelli +58 more
wiley +1 more source
Myocardial revascularization in patients with chronic kidney disease: a systematic review and meta-analysis of surgical versus percutaneous coronary revascularization. [PDF]
Grazioli V +13 more
europepmc +1 more source
Case Series: Extracorporeal Shockwave Myocardial Revascularization Therapy Improves Ischemic Response, Functional Capacity, and Quality of Life in Indicated CABG-Stable Angina Pectoris Patients. [PDF]
Akbar MR +8 more
europepmc +1 more source
HDL function and composition in atherothrombotic cardiovascular disease with very high HDL‐C
We investigated 49 individuals (mean age: 62 ± 2 years, 83% female) with very high HDL‐C (>80 mg/dL), including 23 with ASCVD. Despite matched HDL‐C levels, functional and compositional HDL features differed between groups. CEC differences became evident only after tertile stratification, with ASCVD participants overrepresented in the lowest tertile ...
Teresa Padro +8 more
wiley +1 more source
Risk Factors for Postoperative Atrial Fibrillation in Myocardial Revascularization Surgery: A 15-Year Experience. [PDF]
Bonilla-Bonilla DM +5 more
europepmc +1 more source
ST-elevation myocardial infarction halves expected survival in cancer patients even after effective revascularization [PDF]
D. Garín +5 more
openalex +1 more source
Among 2061 hospitalized HFmrEF patients, low albumin, albumin‐to‐creatinine ratios (ACR), and elevated urea‐to‐albumin ratios (UAR) independently predicted long‐term all‐cause mortality, but not HF‐related rehospitalization. The UAR and ACR did not provide a clinically significant predictive advantage over albumin levels alone. Abstract Background This
Alexander Schmitt +11 more
wiley +1 more source
Trained Immunity and Cardiovascular Risk: An Immunological Perspective
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden +3 more
wiley +1 more source
Frailty as an Independent Predictor of Adverse Outcomes in Patients Undergoing Direct Myocardial Revascularization. [PDF]
Krivoshapova K +3 more
europepmc +1 more source

